GlassScriptPhysician profile
Dalia Contreras
NPI 1336501600
$833.72
in general payments reported to CMS, 2019-2025
11 companies · $402 in 2025
The $402 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.34 · 2022: $134 · 2023: $120 · 2024: $163 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $197.56 | 2021-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Amgen INC. | $124.98 | 2025 | Otezla |
| Neurocrine Biosciences, INC. | $123.76 | 2025 | |
| Incyte Corporation | $120.96 | 2025 | Opzelura |
| Baxter Healthcare | $103.02 | 2022 | |
| Sanofi Pasteur INC. | $50.42 | 2022-2023 | |
| Phadia US INC. | $33.63 | 2023-2024 | Immunocap |
| Glaxosmithkline, LLC. | $25.66 | 2023 | Bexsero |
| Genzyme Corporation | $21.35 | 2024 | |
| Pfizer INC. | $18.59 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $13.79 | 2024 | Kristalose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalia Contreras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.